spacer
home > pmps > Spring 2012
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Spring 2012
   
Text
PDF
bullet
Manufacturing

Production Systems

Automatic Future

Christopher Procyshyn at Vanrx Pharmasystems Inc looks at high mix, low volume manufacturing of aseptic parenteral dosages, and considers how robotic applications may lead to a more effective production cycle.

 

 
view
download pdf

Construction & Technology

Setting the Scene

The first instalment of a two-part article sees Tim Sandle at Bio Products Laboratory and Madhu Raju Saghee atGland Pharma discuss the structure and air management of cleanrooms for pharmaceutical production, giving insight into the best process for their construction.

 
view
download pdf

Air Filtration

On Air

Rob Flaherty at Trion looks at the fan filter unit (FFU) – an important technology for effective cleanroom filtration – and points out the need for more energy-efficient FFUs in the face of higher environmental standards.

 
view
download pdf

Contamination Assessment

Need for Speed

Rapid microbial methods are showing themselves to be the superior form of contamination assessment in pharmaceutical product manufacturing. Cindy Lieberman at Celsis International Ltd highlights the timeline benefits that these techniques provide.

 
view
download pdf

Device Manufacturing and Production

The Whole Proof

A thorough and well-designed proof-of-principle test for pharmaceutical manufacturing machinery can ensure longterm equipment performance, and avoids undesirable labour and expensive remedial action, concludes Tobias Zill at Sortimat, an ATS affiliate.

 
view
download pdf

Automation and Robotics

Fixed Agenda

Peter Cavallo at DENSO Sales California presents the benefits of small assembly robots, which offer a level of adaptability above and beyond that of fixed solutions, allowing manufacturers to cut costs and enjoy a more flexible workflow.

 
view
download pdf

Device Manufacturing

The Right Idea

The skills and experience required to create a high level inhalation device are extensive, and the search for the right partner must be undertaken with several requirements in mind, explains Louise Righton at 3M Drug Delivery Systems.

 
view
download pdf
bullet
Cool Chain, Cargo & Logistics

Cool Chain

Monitoring Value

The special treatment required by parenteral products creates a significant challenge for the cold chain management company. Olivier Simonnot at Sensitech Inc identifies factors that can assist the process, including good warehousing practice.

 
view
download pdf

Temperature-Controlled

Packaging Simplicity Rules

Andrew J Mills at Intelsius analyses the changing trends in drug development and how these will affect the logistics process, resulting in packaging that is tailored to smaller volume but higher value products.

 
view
download pdf
bullet
Drug Delivery 

Delivery Devices

Health and Safety

Ludwig Weibel at Treff AG explores patient requirements for parenteral drugs, and considers how a user-friendly approach can influence the specification for the ideal reconstitution device.

 
view
download pdf

Controlled Release Technology

Sphere of Influence

An expansion in the market for extended release products is expected in the near future, with technologies such as biodegradable PLGA-based microspheres playing a considerable role. Márcio Temtem and José Luís Santos at Hovione SA describe the key characteristics of this delivery platform.

 
view
download pdf
 

Injectable Drug Delivery Systems

Eye on the Needle

The growing demand for advances in fully automatic needle handling systems is leading to real progress in injectable drug delivery device design, as Thomas Jakob at RAUMEDIC AG explains.

 
view
download pdf
bullet
Packaging, Packing & Anti-Counterfeiting

Coding and Labelling

The Elephant in the Room

Several problems with the management of serialisation data have come to the fore recently but, as Magnar Loken at Kezzler AS explains, delivering a system that can combine zero latency, high-volume data management and quick query response times may provide a solution.

 
view
download pdf

Primary Packaging

Material World

Stephen J Duckworth at Clariant International gives a breakdown of material change in primary packaging, and looks at the effect of extractables and leachables, while balancing the need for packaging to branch out in a competitive market.

 
view
download pdf
bullet
Formulations, Ingredients and Excipients

Powder Processing

Site Secrets

Paul Stanway of Powder Systems Ltd discusses how strong powder processing systems are enabling API manufacturing to become more powerful and streamlined, with reference to pertinent realworld applications.

 
view
download pdf

Dosage Forms

Smarter Particle Sizing

As Carl Levoguer at Malvern Instruments shows, the latest particle sizing systems offer ideal resolution levels across broad measurement ranges, effi cient dry dispersion and a small footprint, enabling a higher level of particle assessment than ever before.

 
view
download pdf

Dehydration Technology

High and Dry

Parastoo Yaghmaee at EnWave Corporation presents an alternative to lyophilisation that promises to handle larger dehydration projects in shorter timeframes, cutting manufacturing costs in the process.

 
view
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November

News and Press Releases

Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement